(286 days)
Not Found
No
The summary describes a device that measures pelvic floor angle and motion and displays this data to the user via a smartphone app. It tracks performance over time but does not mention any algorithms or processing that would indicate AI/ML is being used to interpret data, provide personalized feedback beyond simple visualization, or make predictions. The focus is on biofeedback and data tracking.
Yes
The device is described as assisting in "rehabilitation and training of weak pelvic floor muscles for the treatment of stress, mixed and mildmoderate urge incontinence in women," which are therapeutic purposes.
No
This device is intended for rehabilitation and training of weak pelvic floor muscles, not for diagnosing a medical condition. It helps users visualize and perform Kegel exercises based on the angle and motion of the pelvic floor, which is a therapeutic function rather than a diagnostic one.
No
The device description explicitly states that the device consists of hardware components, including a training device and an associated battery-powered electronics box, in addition to the software application and website. The performance studies also include hardware verification testing.
Based on the provided information, the leva Pelvic Floor Trainer is not an In Vitro Diagnostic (IVD) device.
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens (like blood, urine, or tissue) taken from the human body to provide information about a person's health. This testing is done outside of the body (in vitro).
- Leva Pelvic Floor Trainer Function: The leva device is used within the body (vaginally) to directly train and rehabilitate muscles. It measures the physical movement and position of the pelvic floor muscles during exercises. It does not analyze biological specimens.
- Intended Use: The intended use clearly states "rehabilitation and training of weak pelvic floor muscles for the treatment of stress, mixed and mildmoderate urge incontinence in women." This is a therapeutic and training purpose, not a diagnostic one based on analyzing specimens.
- Device Description: The description details a physical device inserted vaginally to facilitate exercises and provide feedback on muscle movement. It doesn't mention any analysis of biological samples.
Therefore, the leva Pelvic Floor Trainer falls under the category of a therapeutic or rehabilitative medical device, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The leva Pelvic Floor Trainer is intended for the purpose of rehabilitation and training of weak pelvic floor muscles for the treatment of stress, mixed and mildmoderate urge incontinence in women. This device interacts with the user via smart phone technology.
Product codes
HIR
Device Description
The leva Rehabilitative Positional Device is a device specifically designed to facilitate Kegel exercise training of women with urinary incontinence by physicians and associated therapists. The device is designed to be discreet and simple to use. Each leva is intended to be used repeatedly by a single patient. The device is designed to be used vaginally.
The RPD hardware consists of the training device itself and an associated battery powered electronics box. The training device has a biocompatible, colored silicone covering which isolates the motion electronics from the environment. The patient inserts the training device in her vagina before commencing Kegel exercises and wirelessly connect the RPD to the smartphone. The training device remains in place during the Kegel exercises. This device can be washed before and after exercise by the patient.
A smartphone, with the appropriate app, is used to connect wirelessly to the RPD and shows the angle of the pelvic floor and the relative motion. This enables the user to visualize the Keqel exercise she is being trained on. The app will carry the information recorded by the patient on her smartphone or tablet. Such information will then connect to a website for the patient or health care provider to store information and retrieve information related to the use of the RPD.
A website is provided for access by the patient, health care provider and insurance company. This website provides utilities for the patient, the health care provider and the insurance company. For the patient the website provides ongoinq tracking of performance—showing improvement in the patient's Keqel exercises when using the RPD. The health care provider shall have access for monitoring their patients' performance.
One RPD is intended for only one patient per device and there is no applicable shelf life for this device.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Vagina
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
The leva Rehabilitative Positional Device has been tested and found to conform to the requirements of IEC 60601-1:2005 (3'd Edition), Medical Electrical Equipment - Part 1: General Requirements for Basic Safety and Essential Performance, IEC 60601-1-2:2007, Medical electrical equipment - Part 1-2: General requirements for basic safety and essential performance - Collateral standard: Electromagnetic compatibility – Requirements and tests, and IEC 60601-1-11 General requirements for basic safety and essential performance -Collateral Standard: Requirements for medical electrical equipment and medical electrical systems used in the home healthcare environment. The results of these tests indicate that the device is safe for the intended use.
The leva Rehabilitative Positional Device has been tested against all of the input requirements, including life flex testing, packaging testing and usability testing. The results of these tests indicate that the device is effective for the intended use.
The testing included: hardware verification testing, electromagnetic compatibility testing, safety evaluation and testing, software validation testing, useability testing, packaging testing, biocompatibility evaluation, and traceability analysis.
As part of the hardware verification testing, leva systems were subjected to testing to ensure that the design device conforms to the requirements of the Marketing Specification, Product Specification and System Hazards Analysis.
Specific device testing included: measurement and inspection of engineering drawings and specifications, testing of the ability of the cable and vaqinal device to withstand pulling for over 1,460 cycles (expected lifetime of the device), cleaning of the device over 1,460 times (expected lifetime of the device), and +/-20° bending of the device for over 1,40 cycles (expected lifetime of the device).
Software validation was performed and successfully completed with no outstanding anomalies. Testing included examination of security of communications between the system components.
Useability testing was performed using lay volunteers and comprised: reading the Instructions for Use and Quick Start Guide, setting up the system, using the system correctly, performing a mock Kegel, interpreting the user interface, cleaning, storage, and disposal. All participants successfully completed all testing.
The packaging with a complete leva System enclosed was subjected to ISTA 2A-2011 "Partial Simulation Performance Test Procedure for Packaged Products 150 Ib (68 kg) or Less" testing, which included: Atmospheric Preconditioning, Atmospheric Conditioning, Compression, Initial Random Vibration, Impacts, Final Random Vibration. The packaging was found to adequately protect the device during shipping and storage.
Biocompatibility evaluation was performed to satisfy ISO 10993-1 and FDA requirements. All patient contacting materials have been tested and passed cytotoxicity, sensitization and irritation or intracutaneous reactivity protocols.
A traceability analysis was also performed, tracing all the requirements from the Marketing Specification, Product Specification and System Hazards Analysis through to the final test reports and results. All requirements for the device have successfully passed testing.
Key Metrics
Not Found
Predicate Device(s)
InCare Pressure Biofeedback Vaginal Probe (K013653)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 884.1425 Perineometer.
(a)
Identification. A perineometer is a device consisting of a fluid-filled sack for intravaginal use that is attached to an external manometer. The devices measure the strength of the perineal muscles by offering resistence to a patient's voluntary contractions of these muscles and is used to diagnose and to correct, through exercise, uninary incontinence or sexual dysfunction.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized symbol that resembles a caduceus, but instead of snakes, it features three abstract human profiles facing right.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
October 9, 2014
Remendium Labs, LLC Yolanda Lorie Chief Operating Officer 340 East Parker Road Baton Rouge, LA 70803
Re: K133990
Trade/Device Name: Ieva Rehabilitative Positional Device Regulation Number: 21 CFR§ 884.1425 Regulation Name: Perineometer Regulatory Class: II Product Code: HIR Dated: September 9, 2014 Received: September 10, 2014
Dear Yolanda Lorie,
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in
1
the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Herbert P. Lerner -S
for
Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
5. Indications for Use Statement
510(k) Number (if known): Original 510(k) Submission - K133990 Device Name: leva Rehabilitative Positional Device Indications for Use:
The leva Pelvic Floor Trainer is intended for the purpose of rehabilitation and training of weak pelvic floor muscles for the treatment of stress, mixed and mildmoderate urge incontinence in women. This device interacts with the user via smart phone technology.
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use AND/OR (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of Center for Devices and Radiological Health (CDRH)
3
Image /page/3/Picture/0 description: The image shows the logo for Remendiumlabs. The logo consists of a blue swirl design on the left and the company name "Remendiumlabs" on the right. The word "Remendium" is in dark blue, while "labs" is in light blue.
510(k) Summary
| Submitter's name and address: | Remendium Labs, LLC
340 East Parker Road
Baton Rouge, LA, USA 70803 |
|-------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact person: | Yolanda Lorie,
Chief Operating Officer
Remendium Labs, LLC
340 East Parker Road
Baton Rouge, LA, USA 70803
Phone: +1-386-717-4360
eMail: ylorie@mac.com |
| Date Summary was prepared: | December 20, 2013 |
| Trade/Proprietary Name: | leva Rehabilitative Positional Device |
| Common/Usual Name: | Pelvic Muscle Exerciser |
| Classification Name: | Perineometer |
| Product Code: | HIR |
| Regulation Number: | 21 CFR 884.1425 |
| Device Classification: | Class II |
| Predicate Devices | InCare Pressure Biofeedback Vaginal
Probe (K013653) |
Device Description 1.1
The leva Rehabilitative Positional Device is a device specifically designed to facilitate Kegel exercise training of women with urinary incontinence by physicians and associated therapists. The device is designed to be discreet and simple to use. Each leva is intended to be used repeatedly by a single patient. The device is designed to be used vaginally.
4
Image /page/4/Picture/0 description: The image shows the logo for Remendiumlabs. The logo consists of a blue and light blue swirl design on the left, followed by the company name "Remendiumlabs" in a stylized font. The word "Remendium" is in dark blue, while "labs" is in light blue.
The RPD hardware consists of the training device itself and an associated battery powered electronics box. The training device has a biocompatible, colored silicone covering which isolates the motion electronics from the environment. The patient inserts the training device in her vagina before commencing Kegel exercises and wirelessly connect the RPD to the smartphone. The training device remains in place during the Kegel exercises. This device can be washed before and after exercise by the patient.
A smartphone, with the appropriate app, is used to connect wirelessly to the RPD and shows the angle of the pelvic floor and the relative motion. This enables the user to visualize the Keqel exercise she is being trained on. The app will carry the information recorded by the patient on her smartphone or tablet. Such information will then connect to a website for the patient or health care provider to store information and retrieve information related to the use of the RPD.
A website is provided for access by the patient, health care provider and insurance company. This website provides utilities for the patient, the health care provider and the insurance company. For the patient the website provides ongoinq tracking of performance—showing improvement in the patient's Keqel exercises when using the RPD. The health care provider shall have access for monitoring their patients' performance.
One RPD is intended for only one patient per device and there is no applicable shelf life for this device.
Intended Use 1.2
The leva Pelvic Floor Trainer is intended for the purpose of rehabilitation and training of weak pelvic floor muscles for the treatment of stress, mixed and mildmoderate urge incontinence in women. This device interacts with the user via smart phone technology.
1.3 Technological Characteristics and Substantial Equivalence
The leva Rehabilitative Positional Device consists of two major components: the vaginal device and an electronics box.
As shown in Table 1, the leva has similar technical characteristics as the predicate devices, and any differences do not affect safety or effectiveness.
5
Image /page/5/Picture/0 description: The image shows the logo for Remendium Labs. The logo consists of a blue and light blue swirl design on the left, followed by the company name "Remendiumlabs" in a stylized font. The word "Remendium" is in dark blue, while "labs" is in light blue.
The InCare device uses the pressure applied to the outside of the probe as the parameter to be reported to the patient to reflect the strength of the Keqel exercise being performed. In practice, the pressure-based devices can reflect the pelvic floor contraction, the vaginal wall contraction or both. If the patient contract's her vaginal wall, the pressure device may read the contraction as a valid Kegel, giving a false impression during training. The set of muscles contracting is therefore important. Anatomically, when the vaginal walls contract, the center line of the vagina does not significantly move, whereas, during a properly performed Kegel, the pelvic floor raises, bending the vagina, and by association, the urethra. The leva RPD uses the accelerometers to determine the relative bend in the probe, between the vaginal entrance and the deep vagina. In this way the leva displays the relative strength of the Kegel by showing the bend and uplift of the pelvic floor. A Kegel with only vaginal wall contraction will show little or no response. Thus the parameter measured by the devices differs, however the intent of displaying the relative intensity of the Kegel exercise is the same.
Each of these sensor systems provides the physician with an objective measure to assist in the training of a patient and the monitoring of the progress of the physician's treatment program.
6
Image /page/6/Picture/0 description: The image shows the logo for Remendiumlabs. The logo consists of a blue swirl graphic on the left and the company name "Remendiumlabs" on the right. The word "Remendium" is in a darker blue color, while the word "labs" is in a lighter blue color.
Table 1 leva Device and Predicate Comparison
| Table 1 leva Device and Predicate Comparison | ||
|---|---|---|
| Device | Submitted Device | Predicate |
| Device | leva | InCare Pressure Biofeedback Vaginal Probe |
| Manufacturer | Remendium Labs, LLC | Hollister Incorporated |
| K Number | TBD | K013653 |
| Common or Usual Name | Pelvic Muscle Exerciser | Pelvic Muscle Exerciser |
| Regulation Number | 884.1425 | 884.1425 |
| Product Code | HIR | HIR |
| Intended Use | The 'leva' Pelvic Floor Trainer is intended for the purpose of rehabilitation and training of weak pelvic floor muscles for the treatment of stress urge and mixed urinary incontinence in women. This device interacts with the user via smart phone technology. | The InCare Pressure Biofeedback Vaginal Pressure Probe and Anal Pressure Probe are intended to provide pressure biofeedback from pelvic musculature for the purpose of rehabilitation of weak pelvic floor muscles in the treatment of urinary incontinence. |
| Purpose | Vaginal exerciser/trainer | Vaginal exerciser/trainer |
| Principle of Operation | Provides indication of relative intensity of pelvic floor muscle contraction | Provides indication of relative intensity of pelvic floor muscle contraction |
| Muscle Stimulation | No | No |
| Parameter | Relative position of device | Pressure applied to device |
| Target Population | Women with mild incontinence | Women with mild incontinence |
| Anatomical Site | Vagina | Vagina |
| Single Patient Device | Yes | Yes |
| Reusable | Yes | Yes |
| Sterile | Clean, non-sterile | Clean, non-sterile |
| Information Display | Graphical and numeric based on applied bending, anatomical overlay | Graphical based on applied pressure |
| Probe Covering Material | Silicone | Silicone |
| Biocompatibility | ISO 10993-1 | ISO 10993-1 |
| Instructions for Use | Manual | Manual |
| Cleaning | Washable | Washable |
7
Image /page/7/Picture/0 description: The image shows the logo for Remendiumlabs. The logo consists of a stylized blue swirl on the left, followed by the company name "Remendiumlabs" in blue text. The "Remendium" part of the name is in a darker blue, while the "labs" part is in a lighter blue.
1.4 Safetv evaluation
The leva Rehabilitative Positional Device has been tested and found to conform to the requirements of IEC 60601-1:2005 (3'd Edition), Medical Electrical Equipment - Part 1: General Requirements for Basic Safety and Essential Performance, IEC 60601-1-2:2007, Medical electrical equipment - Part 1-2: General requirements for basic safety and essential performance - Collateral standard: Electromagnetic compatibility – Requirements and tests, and IEC 60601-1-11 General requirements for basic safety and essential performance -Collateral Standard: Requirements for medical electrical equipment and medical electrical systems used in the home healthcare environment. The results of these tests indicate that the device is safe for the intended use.
Summary of Effectiveness Data 1.5
The leva Rehabilitative Positional Device has been tested against all of the input requirements, including life flex testing, packaging testing and usability testing. The results of these tests indicate that the device is effective for the intended use.
The testing included: hardware verification testing, electromagnetic compatibility testing, safety evaluation and testing, software validation testing, useability testing, packaging testing, biocompatibility evaluation, and traceability analysis.
As part of the hardware verification testing, leva systems were subjected to testing to ensure that the design device conforms to the requirements of the Marketing Specification, Product Specification and System Hazards Analysis.
Specific device testing included: measurement and inspection of engineering drawings and specifications, testing of the ability of the cable and vaqinal device to withstand pulling for over 1,460 cycles (expected lifetime of the device), cleaning of the device over 1,460 times (expected lifetime of the device), and +/-20° bending of the device for over 1,40 cycles (expected lifetime of the device).
Software validation was performed and successfully completed with no outstanding anomalies. Testing included examination of security of communications between the system components.
Useability testing was performed using lay volunteers and comprised: reading the Instructions for Use and Quick Start Guide, setting up the system, using the system correctly, performing a mock Kegel, interpreting the user interface, cleaning, storage, and disposal. All participants successfully completed all testing.
8
Image /page/8/Picture/0 description: The image shows the logo for Remendiumlabs. The logo consists of a blue and light blue swirl design on the left, followed by the text "Remendiumlabs" in blue. The "labs" portion of the text is in a lighter shade of blue than the "Remendium" portion.
The packaging with a complete leva System enclosed was subjected to ISTA 2A-2011 "Partial Simulation Performance Test Procedure for Packaged Products 150 Ib (68 kg) or Less" testing, which included: Atmospheric Preconditioning, Atmospheric Conditioning, Compression, Initial Random Vibration, Impacts, Final Random Vibration. The packaging was found to adequately protect the device during shipping and storage.
Biocompatibility evaluation was performed to satisfy ISO 10993-1 and FDA requirements. All patient contacting materials have been tested and passed cytotoxicity, sensitization and irritation or intracutaneous reactivity protocols.
A traceability analysis was also performed, tracing all the requirements from the Marketing Specification, Product Specification and System Hazards Analysis through to the final test reports and results. All requirements for the device have successfully passed testing.
1.6 Conclusion
The leva Rehabilitative Positional Device has been shown to be safe through extensive bench testing, to have a intuitive and usable interface and is substantially equivalent to its predicate device: InCare Pressure Biofeedback Vaginal Probe (K013653); and that the technical differences between the devices do not raise any new questions of safety or effectiveness